A phase II trial of neoadjuvant docetaxel/5-FU/cisplatin in combination with prophylactic pegteograstim in unresectable, locally advanced nasal cavity/paranasal squamous cell carcinoma: KCSG HN18-07

被引：0
|
作者：
An, Hojung
Keam, Bhumsuk
Shin, Seong Hoon
Kim, Min Kyoung
Kim, Sung-Bae
机构：
[1] Catholic Univ Korea, St Vincents Hosp, Suwon, South Korea
[2] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea
[3] Kosin Univ, Gospel Hosp, Busan, South Korea
[4] Yeungnam Univ Univ Hosp, Daegu, South Korea
[5] Univ Ulsan, Asan Med Ctr, Coll Med, Seoul, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6020
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Neoadjuvant triplet chemotherapy with docetaxel, cisplatin plus 5-FU vs docetaxel, cisplatin plus S-1 for advanced esophageal squamous cell carcinoma: Propensity score matched analysis
    Kitadani, Junya
    Ojima, Toshiyasu
    Hayata, Keiji
    Goda, Taro
    Takeuchi, Akihiro
    Tominaga, Shinta
    Fukuda, Naoki
    Nakai, Tomoki
    Yamaue, Hiroki
    Kawai, Manabu
    ONCOLOGY, 2024, 102 (03) : 228 - 238
  • [22] Preoperative cisplatin, 5-FU and radiotherapy in squamous cell esophageal carcinoma. Multicentric phase II trial FFCD 8804
    Bedenne, L
    Seitz, JF
    Milan, C
    Renard, P
    Fraisse, J
    Conroy, T
    Lacourt, J
    Janoray, P
    Faivre, J
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 1998, 22 (03): : 273 - 281
  • [23] Neoadjuvant chemotarget therapy with cetuximab, docetaxel, and cisplatin in locally advanced resectable oral/oropharygeal squamous cell carcinoma: A multicenter phase III trial (Eagle trial)
    Zhong, L-P.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S848 - S849
  • [24] Phase I study of cetuximab (CET) in combination with 5-fluorouracil (5-FU), cisplatin (CP), and radiotherapy (RT) in patients with locally advanced squamous cell anal carcinoma (LAAC)
    Olivatto, L. O.
    Meton, F.
    Bezerra, M.
    Cardoso, A.
    Araujo, C. M.
    Castro, L.
    Moura, R.
    Pereira, V.
    Ferreira, C. G.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [25] Phase II trial of docetaxel, cisplatin, 5-fluorouracil (TPF) in locally advanced and metastatic squamous cell carcinoma (SCC) of the penis (CRUK/09/001).
    Bahl, Amit
    Nicholson, Steve
    Harland, Stephen John
    Chester, John D.
    Pickering, Lisa M.
    Barber, Jim
    Cruickshank, Clare
    Burnett, Stephanie M.
    Waters, Rachel
    Hall, Emma
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [26] Erratum to: Phase II trial of biweekly docetaxel, cisplatin, and 5-fluorouracil chemotherapy for advanced esophageal squamous cell carcinoma
    Yoshihiro Tanaka
    Kazuhiro Yoshida
    Atsuko Yamada
    Toshiyuki Tanahashi
    Naoki Okumura
    Nobuhisa Matsuhashi
    Kazuya Yamaguchi
    Tatsuhiko Miyazaki
    Cancer Chemotherapy and Pharmacology, 2016, 77 : 1153 - 1155
  • [27] A phase II trial of continuous 5-fluorouracil (5-FU) in recurrent locally advanced or metastatic transitional cell carcinoma of the urinary tract
    Highley, M
    Griffiths, G
    Uscinska, B
    Harper, P
    Huddart, R
    Barber, J
    BRITISH JOURNAL OF CANCER, 2001, 85 : 52 - 52
  • [28] Concomitant radiochemotherapy with cisplatin (CDDP), 5-fluorouracil (5-FU) and mitomycin C (MMC) in locally advanced oropharyngeal carcinoma: Results of a phase II trial
    Berger, C
    Chapet, S
    Calais, G
    ReynaudBougnoux, A
    Garand, G
    LeFloch, O
    BULLETIN DU CANCER, 1995, 82 (12) : 1044 - 1051
  • [29] Phase II trial of concurrent bio-chemoradiotherapy using docetaxel, cisplatin, and cetuximab for locally advanced head and neck squamous cell carcinoma
    Nishimura, Goshi
    Taguchi, Takahide
    Takahashi, Masahiro
    Shiono, Osamu
    Komatsu, Masanori
    Sano, Daisuke
    Yabuki, Kenichiro
    Arai, Yasuhiro
    Takahashi, Hideaki
    Hata, Masaharu
    Oridate, Nobuhiko
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2016, 77 (06) : 1315 - 1319
  • [30] Phase II trial of concurrent bio-chemoradiotherapy using docetaxel, cisplatin, and cetuximab for locally advanced head and neck squamous cell carcinoma
    Goshi Nishimura
    Takahide Taguchi
    Masahiro Takahashi
    Osamu Shiono
    Masanori Komatsu
    Daisuke Sano
    Kenichiro Yabuki
    Yasuhiro Arai
    Hideaki Takahashi
    Masaharu Hata
    Nobuhiko Oridate
    Cancer Chemotherapy and Pharmacology, 2016, 77 : 1315 - 1319
12345